Gastrointestinal Cancer News

Active cancer treatment is associated with increased risk for sudden cardiac death, especially among patients younger than 74 years old and those with a history of heart failure, results from a retrospective study showed.

Most childhood cancer survivors are not up to date on guideline-recommended screening for late effects of cancer treatment or second malignancies, according to study results.

Beta-blocker therapy did not reduce negative intrusive thoughts or anxiety among cancer survivors, according to results of an emulated trials analysis published in BMC Cancer.

WASHINGTON — A blood-based screening test detected colorectal cancer with a sensitivity of 79.2% and a specificity of 91.5% among average-risk adults aged 45 to 85 years, according to research presented at Digestive Disease Week.

WASHINGTON — Oral antibiotic use among adult patients was not associated with increased risk for early-onset colorectal cancer, according to data presented at Digestive Disease Week.

An analysis of global online conversations among health care professionals on social media in April revealed tremendous enthusiasm about FDA approval of a treatment for adults with advanced HER2-positive solid tumors.

WASHINGTON — An algorithm that uses electronic health record parameters identified glycemic evidence of new-onset diabetes in real time, which could lead to earlier detection of pancreatic ductal adenocarcinoma, according to researchers.

Patients participating in clinical trials for anticancer drugs do not gain a survival benefit compared with individuals who received routine care, according to study results published in JAMA.

WASHINGTON — Provider recommendation was a major influencer for colonoscopy screening for young adults at average risk for colorectal cancer, especially non-Hispanic Black patients, according to data presented at Digestive Disease Week.

WASHINGTON — In a Healio video exclusive, Saqr Alsakarneh, MD, MSc, describes “significant disparities” in race, ethnicity and sex among participants enrolled clinical trials for liver transplantation in the U.S.